 CAMBRIDGE, Mass. BEIJING--BUSINESS WIRE--- BGNE BTKi--BeiGene, Ltd. NASDAQ: BGNE; HKEX: 06160, a global biotechnology company focused on developing and commercializing innovative medicines worldwide, today announced that clinical results from its broad hematology program will be presented at the 26th European Hematology Association 2021 EHA2021 Virtual Congress being held June 9 17, 2021. Following key head-to-head data from the positive ALPINE trial interim analysis and the previously announced 